查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585765

骨髓移植市場：按類型、治療類型、最終用戶分類 - 2025-2030 年全球預測

Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年骨髓移植市值為162.7億美元，預計到2024年將達到176.2億美元，複合年成長率為8.74%，預計到2030年將達到292.6億美元。

骨髓移植 (BMT) 涉及以健康的骨髓幹細胞取代受損或患病的骨髓，這對於治療白血病、淋巴瘤和其他血液疾病等疾病至關重要。自體、同種異體和同基因移植可供選擇，每種移植都滿足不同的臨床需求，將其應用擴展到各種血液學和免疫不全症。這些疾病的日益普及正在推動 BMT 的需求和應用，並得到醫療技術進步和政府支持政策的進一步支持。 BMT 意識的提高、成功率的提高以及幹細胞捐贈者數量的增加是成長的主要驅動力。然而，它面臨著高昂的手術成本、嚴格的監管以及移植物抗宿主疾病等併發症風險等挑戰，這可能會限制市場的成長軌跡。

主要市場統計
基準年[2023] 162.7億美元
預測年份 [2024] 176.2億美元
預測年份 [2030] 292.6億美元
複合年成長率（%） 8.74%

最終用途範圍主要是醫院、診所和專門的癌症治療中心，並不斷增加對先進 BMT 設施的投資，以提高治療效果和患者預後。最近的市場開拓趨勢揭示了基因匹配技術和幹細胞冷凍保存的潛在商機。該領域的公司可以透過專注於個人化醫療和改善捐贈者-接受者配對系統的物流來利用這些趨勢。此外，減少移植後併發症的技術創新為產業相關人員提供了寶貴的研發途徑。迫切需要具有成本效益的治療通訊協定和以患者為中心的護理模式來緩解限制。

市場的本質是動態的，對再生醫學和基因組學研究有強烈的傾向，為創新提供了肥沃的土壤。專注於將人工智慧融入治療計劃並利用遠端醫療進行諮詢的公司可以提高可及性和業務效率。透過優先與學術研究機構合作以促進創新，相關人員可以確保競爭優勢。因此，瞄準免疫療法的進步、加強全球捐助者登記以及投資於公眾意識宣傳活動是抓住新市場機會並促進 BMT 市場持續成長的戰略舉措。

市場動態：揭示快速發展的骨髓移植市場的關鍵市場洞察

供需的動態交互作用正在改變骨髓移植市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 血癌的盛行率和改善骨髓移植的機會
    • 細胞治療和組織工程產品的商業化程度提高
    • 政府努力提高治療方法意識
  • 市場限制因素
    • 治療費用上漲且無法報銷
  • 市場機會
    • 骨髓移植治療的技術進步
    • BMT 正在進行的研發活動
  • 市場挑戰
    • 對 GVHD、感染疾病和復發的擔憂

波特五力：駕馭骨髓移植市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解骨髓移植市場的外部影響

外部宏觀環境因素在塑造骨髓移植市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解骨髓移植市場的競爭格局

骨髓移植市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣骨髓移植市場供應商的績效評估

FPNV定位矩陣是評估骨髓移植市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製骨髓移植市場的成功之路

骨髓移植市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高血癌骨髓移植的盛行率和可近性
      • 細胞治療和組織工程產品的商業化程度提高
      • 政府努力提高治療方法意識
    • 抑制因素
      • 治療費用高且無補償
    • 機會
      • 骨髓移植治療的技術進步
      • BMT 正在進行的研發活動
    • 任務
      • 對 GVHD、感染疾病和復發的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章骨髓移植市場：依類型

  • 同種異體移植
  • 自體移植

第7章依治療類型分類的骨髓移植市場

  • 再生障礙性貧血
  • 白血病
  • 淋巴瘤
  • 骨髓發育不良症候群
  • 骨髓瘤
  • 骨髓增生性疾病
  • 鐮狀細胞性貧血
  • 固態腫瘤
  • 地中海型貧血

第8章骨髓移植市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 多學科診所

第9章 北美及南美骨髓移植市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太骨髓移植市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲骨髓移植市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • American Type Culture Collection
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • FUJIFILM Cellular Dynamics, Inc.
  • Gamida Cell
  • Hemacare Corporation
  • Lifeline Cell Technology
  • Lonza Group AG
  • Magenta Therapeutics, Inc.
  • Merck KgaA
  • Mesoblast Ltd.
  • Novartis AG
  • PromoCell GmbH
  • Qiagen NV
  • ReeLabs Pvt. Ltd.
  • Sanofi-Aventis LLC
  • ScienCell Research Laboratories, Inc.
  • STEMCELL Technologies Inc.
Product Code: MRR-957C47F8F271

The Bone Marrow Transplantation Market was valued at USD 16.27 billion in 2023, expected to reach USD 17.62 billion in 2024, and is projected to grow at a CAGR of 8.74%, to USD 29.26 billion by 2030.

Bone marrow transplantation (BMT) involves replacing damaged or diseased bone marrow with healthy marrow stem cells, essential for treating conditions such as leukemia, lymphoma, and other blood disorders. It encompasses autologous, allogeneic, and syngeneic transplant types, each serving different clinical requirements, thereby expanding its applicability across various hematological and immune deficiency conditions. The increasing prevalence of these diseases is compelling the necessity and application of BMT, further driven by advancements in medical technology and supportive government policies. Significant growth influences include rising awareness about BMT, improved success rates, and a growing number of stem cell donors. However, the market faces challenges such as high procedural costs, stringent regulations, and the risk of complications like graft-versus-host disease, which can limit its growth trajectory.

KEY MARKET STATISTICS
Base Year [2023] USD 16.27 billion
Estimated Year [2024] USD 17.62 billion
Forecast Year [2030] USD 29.26 billion
CAGR (%) 8.74%

The end-use scope primarily spans hospitals, clinics, and specialized cancer treatment centers which are increasingly investing in advanced BMT facilities to enhance treatment efficacy and patient outcomes. Recent market insights reveal that ongoing developments in genetic matching technologies and cryopreservation of stem cells present potential opportunities. Businesses in the sector can capitalize on these trends by focusing on personalized medicine and improving logistics for donor-recipient matching systems. Moreover, innovations in reducing post-transplant complications offer valuable research and development avenues for industry stakeholders. To mitigate limitations, there is a pressing need for cost-effective treatment protocols and patient-centric care models.

The market's nature is dynamic, with a robust inclination towards research in regenerative medicine and genomics, providing fertile ground for innovation. Companies focusing on integration of artificial intelligence in treatment planning and leveraging telemedicine for consultation can enhance accessibility and operational efficiency. By prioritizing collaborations with academic and research institutions to foster innovation, stakeholders can secure a competitive edge. Thus, targeting advancements in immunotherapy, enhancing global donor registries, and investing in public awareness campaigns are strategic steps for capturing emerging market opportunities and driving sustainable growth in the BMT market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Marrow Transplantation Market

The Bone Marrow Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of blood cancer and improving accessibility to bone marrow transplantation
    • Increased commercialization of cell therapy and tissue engineering products
    • Government initiatives to improve awareness of the therapy
  • Market Restraints
    • High cost of the treatment and lack of reimbursement
  • Market Opportunities
    • Technological advancements in bone marrow transplantation therapy
    • Ongoing research & development activities of BMT
  • Market Challenges
    • Concerns related to GVHD, infections and relapse

Porter's Five Forces: A Strategic Tool for Navigating the Bone Marrow Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Marrow Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Marrow Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Marrow Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Marrow Transplantation Market

A detailed market share analysis in the Bone Marrow Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Marrow Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Marrow Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Marrow Transplantation Market

A strategic analysis of the Bone Marrow Transplantation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Marrow Transplantation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Type Culture Collection, Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol Myers Squibb, Eli Lilly and Company, FUJIFILM Cellular Dynamics, Inc., Gamida Cell, Hemacare Corporation, Lifeline Cell Technology, Lonza Group AG, Magenta Therapeutics, Inc., Merck KgaA, Mesoblast Ltd., Novartis AG, PromoCell GmbH, Qiagen N.V., ReeLabs Pvt. Ltd., Sanofi-Aventis LLC, ScienCell Research Laboratories, Inc., and STEMCELL Technologies Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Marrow Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Allogeneic Transplant and Autologous Transplant.
  • Based on Treatment Type, market is studied across Aplastic Anemia, Leukemia, Lymphoma, Myelodysplastic Syndrome, Myeloma, Myeloproliferative Disorders, Sickle cell Anemia, Solid Tumors, and Thalassemia.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Multi-Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of blood cancer and improving accessibility to bone marrow transplantation
      • 5.1.1.2. Increased commercialization of cell therapy and tissue engineering products
      • 5.1.1.3. Government initiatives to improve awareness of the therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the treatment and lack of reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in bone marrow transplantation therapy
      • 5.1.3.2. Ongoing research & development activities of BMT
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to GVHD, infections and relapse
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bone Marrow Transplantation Market, by Type

  • 6.1. Introduction
  • 6.2. Allogeneic Transplant
  • 6.3. Autologous Transplant

7. Bone Marrow Transplantation Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Aplastic Anemia
  • 7.3. Leukemia
  • 7.4. Lymphoma
  • 7.5. Myelodysplastic Syndrome
  • 7.6. Myeloma
  • 7.7. Myeloproliferative Disorders
  • 7.8. Sickle cell Anemia
  • 7.9. Solid Tumors
  • 7.10. Thalassemia

8. Bone Marrow Transplantation Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Multi-Specialty Clinics

9. Americas Bone Marrow Transplantation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bone Marrow Transplantation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bone Marrow Transplantation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. American Type Culture Collection
  • 3. Bayer AG
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bristol Myers Squibb
  • 7. Eli Lilly and Company
  • 8. FUJIFILM Cellular Dynamics, Inc.
  • 9. Gamida Cell
  • 10. Hemacare Corporation
  • 11. Lifeline Cell Technology
  • 12. Lonza Group AG
  • 13. Magenta Therapeutics, Inc.
  • 14. Merck KgaA
  • 15. Mesoblast Ltd.
  • 16. Novartis AG
  • 17. PromoCell GmbH
  • 18. Qiagen N.V.
  • 19. ReeLabs Pvt. Ltd.
  • 20. Sanofi-Aventis LLC
  • 21. ScienCell Research Laboratories, Inc.
  • 22. STEMCELL Technologies Inc.

LIST OF FIGURES

  • FIGURE 1. BONE MARROW TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 2. BONE MARROW TRANSPLANTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BONE MARROW TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BONE MARROW TRANSPLANTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY ALLOGENEIC TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY AUTOLOGOUS TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY APLASTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOPROLIFERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY SICKLE CELL ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023